mhurhangee/patent-ind-claim-en huggingface dataset:
A compound selected from the group consisting of : a) b) c) wherein R 1 is a C 1 -C 3 alkyl; d) wherein R 1 is a C 1 -C 3 alkyl; and e) wherein R 1 is a C 3 alkyl. a) b) c) wherein R 1 is a C 1 -C 3 alkyl; d) wherein R 1 is a C 1 -C 3 alkyl; and e) wherein R 1 is a C 3 alkyl.
Glass pane construction, particularly bullet proof glass pane (1; 1.1) to be used in a motor vehicle, having several transparent panes and layers made of glass, ceramic, or synthetic material, which are connected in a layered manner in a laminate for providing a laminated window, which comprises transparent UV filtering layer means (3; 3.5) for reflecting of ultraviolet (UV) radiation and electrically controllable or switchable electrochromic layer means for electrical controlling or switching of the light transparency of the glass pane construction or of the bulletproof glass pane (1; 1.1; 1.3), characterized in that the UV filtering layer means comprises at least one cholesteric layer (3.2; 3.52, 3.54) that reflects UV radiation for avoiding UV radiation impinging onto the electrochromic layer means , wherein the cholesteric layer (3.2; 3.52; 3.54) has a reflection maximum at an ultraviolet wavelength in a range between 300 and 400 nm, and an outer pane made of glass or glass ceramic is provided and the UV filtering layer means (3; 3.5) adjoins the outer pane .
A method of guiding a clinician performed by an ultrasound imaging system having a user interface, a control unit, a memory and an image display device comprising: obtaining patient information along with a relevant clinical procedure through a user interface; selecting a predefined workflow and at least one device setting parameter from an information library, based on a clinician decision obtained through user interface; communicating the selected workflow including the steps in the workflow to the clinician in real time using the image display device, upon initiating the clinical procedure; and configuring the imaging system using the selected device setting parameter to perform the selected workflow; wherein communicating the selected workflow further comprises: annotating an image based on at least one of the patient information and steps in the workflow, the image including sample images and real time images of the patient; displaying annotated image , corresponding to each step in the clinical workflow, at least one of besides and blended into the real time image; and interacting a clinician with the annotated image . obtaining patient information along with a relevant clinical procedure through a user interface; selecting a predefined workflow and at least one device setting parameter from an information library, based on a clinician decision obtained through user interface; communicating the selected workflow including the steps in the workflow to the clinician in real time using the image display device, upon initiating the clinical procedure; and configuring the imaging system using the selected device setting parameter to perform the selected workflow; wherein communicating the selected workflow further comprises: annotating an image based on at least one of the patient information and steps in the workflow, the image including sample images and real time images of the patient; displaying annotated image , corresponding to each step in the clinical workflow, at least one of besides and blended into the real time image; and interacting a clinician with the annotated image .
A method for classifying microwave link data of a microwave system comprising a point-to-point wireless microwave link , the method being performed by a controller entity , the method comprising: obtaining (S102), in time windows, microwave link data in terms of signal quality measurement values and received power values for the point-to-point wireless microwave link ; and classifying (S104), per time window, the microwave link data per time window to operating conditions in a set of operating conditions by, from the signal quality measurement values and received power values per time window, estimating probability values ({p k }) for each of the operating conditions according to a mapping ({m jk }), as learned through training, between pieces of microwave link data and operating conditions. obtaining (S102), in time windows, microwave link data in terms of signal quality measurement values and received power values for the point-to-point wireless microwave link ; and classifying (S104), per time window, the microwave link data per time window to operating conditions in a set of operating conditions by, from the signal quality measurement values and received power values per time window, estimating probability values ({p k }) for each of the operating conditions according to a mapping ({m jk }), as learned through training, between pieces of microwave link data and operating conditions.
A carrier cell, comprising an oncolytic virus, wherein: the virus can replicate in the carrier cell; the carrier cell can be administered to a human subject; the carrier cell has been treated or modified or both to enhance the immunosuppressive properties or immunoprivileged properties of the cell for administration to a human subject, wherein the treated or modified carrier cell is: an engineered cell that expresses single-chain antibodies that target or deplete NK and/or NKT cells, and/or γδ T cells, and/or an engineered cell that expresses protein antagonists of complement proteins and/or protein antagonists of neutralizing antibodies; and optionally, the cell has been treated or modified to enhance amplification of the virus in the cell, wherein the treatment or modification comprises loading the cell with a growth factor or a cytokine. the virus can replicate in the carrier cell; the carrier cell can be administered to a human subject; the carrier cell has been treated or modified or both to enhance the immunosuppressive properties or immunoprivileged properties of the cell for administration to a human subject, wherein the treated or modified carrier cell is: an engineered cell that expresses single-chain antibodies that target or deplete NK and/or NKT cells, and/or γδ T cells, and/or an engineered cell that expresses protein antagonists of complement proteins and/or protein antagonists of neutralizing antibodies; and an engineered cell that expresses single-chain antibodies that target or deplete NK and/or NKT cells, and/or γδ T cells, and/or an engineered cell that expresses protein antagonists of complement proteins and/or protein antagonists of neutralizing antibodies; and optionally, the cell has been treated or modified to enhance amplification of the virus in the cell, wherein the treatment or modification comprises loading the cell with a growth factor or a cytokine.
A compound of formula I-1a wherein A is N or CH; R 1 is C 1 -C 4 alkyl; R 2a is C 1 -C 4 haloalkyl; R 3 is hydrogen, halogen, C 2 -C 6 alkenyl, C 1 -C 4 haloalkyl or C 3 -C 6 cycloalkyl; or R 3 is phenyl which can be mono- or di-substituted by substituents selected from the group consisting of cyano, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy and C 1 -C 4 haloalkyl; or R 3 is pyrazolyl, which can be mono-substituted by C 1 -C 4 haloalkyl; or R 3 is pyridinyl which can be mono- or di-substituted by substituents selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and halogen; or R 3 is pyrimidinyl which can be mono-substituted by C 1 -C 4 alkoxy; R 4 is C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, preferably 1,1,1-trifluoroethyl; or R 4 is C 1 -C 4 alkyl mono-substituted by cyano, C 1 -C 4 alkylsulfanyl, phenyl, C 1 -C 4 alkoxy, C 1 -C 4 alkoxy C 1 -C 4 alkoxy or C 3 -C 6 cycloalkyl; or R4 is C 2 -C 6 alkenyl or C 2 -C 6 alkynyl; or R 4 is C 2 -C 6 alkenyl substituted by phenyl; R 4 is benzyl which can be mono-substituted by C 1 -C 4 alkoxy; R 8 is methyl; and X is S or SO 2 ; and agrochemically acceptable salts, stereoisomers, enantiomers and N-oxides of the compounds of formula I-1a. A is N or CH; R 1 is C 1 -C 4 alkyl; R 2a is C 1 -C 4 haloalkyl; R 3 is hydrogen, halogen, C 2 -C 6 alkenyl, C 1 -C 4 haloalkyl or C 3 -C 6 cycloalkyl; or R 3 is phenyl which can be mono- or di-substituted by substituents selected from the group consisting of cyano, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy and C 1 -C 4 haloalkyl; or R 3 is pyrazolyl, which can be mono-substituted by C 1 -C 4 haloalkyl; or R 3 is pyridinyl which can be mono- or di-substituted by substituents selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and halogen; or R 3 is pyrimidinyl which can be mono-substituted by C 1 -C 4 alkoxy; R 4 is C 1 -C 6 alkyl or C 1 -C 6 haloalkyl, preferably 1,1,1-trifluoroethyl; or R 4 is C 1 -C 4 alkyl mono-substituted by cyano, C 1 -C 4 alkylsulfanyl, phenyl, C 1 -C 4 alkoxy, C 1 -C 4 alkoxy C 1 -C 4 alkoxy or C 3 -C 6 cycloalkyl; or R4 is C 2 -C 6 alkenyl or C 2 -C 6 alkynyl; or R 4 is C 2 -C 6 alkenyl substituted by phenyl; R 4 is benzyl which can be mono-substituted by C 1 -C 4 alkoxy; R 8 is methyl; and X is S or SO 2 ; and agrochemically acceptable salts, stereoisomers, enantiomers and N-oxides of the compounds of formula I-1a.
Orthodontic screw comprising two bodies connected by means of positioning means adapted to allow the distance between said bodies to be adjusted with a reciprocal movement along a predetermined direction (F), wherein said bodies have a seat adapted to receive a portion of a connecting structure associable with the orthodontic screw for its connection to the teeth of a dental arch, wherein said seat consists of a groove formed on an external surface of the bodies , so that said portion of said connecting structure can be inserted in said seat through a displacement (Y) orthogonal to the same seat , characterized in that said seat is closed at one of its ends and in that said seat develops parallel to said direction (F).
An ultrasound apparatus comprising a screen which is a touch screen, wherein the ultrasound apparatus is configured to: in response to a user input on a initialization button for initializing a gain with respect to ultrasound image data along depths of an ultrasound image, display, on a first area of the screen, an initial gain on a gain setup window along the depths of the ultrasound image; display, on a second area of the screen, the ultrasound image to which the initial gain is applied; display, on a third area of the screen, a list of a plurality of preset gains which comprise images of gain lines or images including a plurality of slide bars corresponding to the plurality of preset gains; receive a drag input on the gain setup window in a form of a straight line or a curved line; display a gain line on the second area of the screen adjacent to the ultrasound image, wherein the gain line is obtained based on a dragged position of the drag input on the gain setup window; display an updated ultrasound image by applying gains which are extracted from the drag input to the ultrasound image data; store the gains which are extracted from the drag input; and display an image of a gain line or slide bars corresponding to the gain which are extracted from the drag input, on the list of the plurality of preset gains. in response to a user input on a initialization button for initializing a gain with respect to ultrasound image data along depths of an ultrasound image, display, on a first area of the screen, an initial gain on a gain setup window along the depths of the ultrasound image; display, on a second area of the screen, the ultrasound image to which the initial gain is applied; display, on a third area of the screen, a list of a plurality of preset gains which comprise images of gain lines or images including a plurality of slide bars corresponding to the plurality of preset gains; receive a drag input on the gain setup window in a form of a straight line or a curved line; display a gain line on the second area of the screen adjacent to the ultrasound image, wherein the gain line is obtained based on a dragged position of the drag input on the gain setup window; display an updated ultrasound image by applying gains which are extracted from the drag input to the ultrasound image data; store the gains which are extracted from the drag input; and display an image of a gain line or slide bars corresponding to the gain which are extracted from the drag input, on the list of the plurality of preset gains.
A nucleus for an artificial disc for replacing the natural disc of a human spine and being adapted to fit between and move relative to upper and lower end plates that are attached to adjacent vertebrae, comprising: a. a nucleus body having at least one bearing surface for engaging a cooperating bearing surface formed on one or more of the end plates, respectively; b. said at least one bearing surface having a curved portion that is adapted to engage the cooperating bearing surface on said one of the end plates; c. a flattened portion formed on the curved portion for maintaining a preferred orientation of at least one of the end plates relative to the nucleus; characterized in that the nucleus has a horizontal axis and the flattened portion is formed at an angle other than parallel relative to the horizontal axis for maintaining a correction orientation of the artificial disc when the nucleus engages the end plates, wherein the flattened portion is planar, or slightly convex or concave with a radius of curvature different from the adjacent surface to the flattened portion. a. a nucleus body having at least one bearing surface for engaging a cooperating bearing surface formed on one or more of the end plates, respectively; b. said at least one bearing surface having a curved portion that is adapted to engage the cooperating bearing surface on said one of the end plates; c. a flattened portion formed on the curved portion for maintaining a preferred orientation of at least one of the end plates relative to the nucleus;
A fully human antibody of an IgG class, or an antigen-binding portion thereof, that binds to a human CC-Chemokine Receptor 2 (CCR2) epitope with a binding affinity of at least 10 -6 M, wherein said antibody or antigen-binding portion thereof comprises a heavy chain variable domain comprising an amino acid sequence as set forth in SEQ ID NO. 1, and comprises a light chain variable domain comprising an amino acid sequence as set forth in SEQ ID NO. 2 or SEQ ID NO. 32; and wherein the antibody, or antigen-binding portion thereof, further binds to murine CCR2.
A system , comprising: an enclosure; a battery energy storage system BESS with a plurality of batteries; and an inverter having a minimum output of 250 kW; wherein the BESS and the inverter share at least one protection circuit and are co-located in the enclosure; wherein the system further comprises: a single lock out/tag out LOTO system disposed at an output stage of the inverter ; and a thermal management system, wherein the BESS and the inverter are cooled by the thermal management system. an enclosure; a battery energy storage system BESS with a plurality of batteries; and an inverter having a minimum output of 250 kW; wherein the BESS and the inverter share at least one protection circuit and are co-located in the enclosure; wherein the system further comprises: a single lock out/tag out LOTO system disposed at an output stage of the inverter ; and a thermal management system, wherein the BESS and the inverter are cooled by the thermal management system. a single lock out/tag out LOTO system disposed at an output stage of the inverter ; and a thermal management system, wherein the BESS and the inverter are cooled by the thermal management system.
A haptic button assembly comprising: a housing comprising a cavity ; a button provided within the cavity and moveable along a first axis within the cavity, wherein the first axis is perpendicular to a contact surface of the button; at least one intermediate moveable element provided within the cavity in contact with the button and moveable in a plane defined by the first axis and a second axis, the second axis being perpendicular to the first axis, and arranged to drive movement of the button along the first axis, wherein the at least one intermediate moveable element is in indirect contact with the button, and the assembly comprises a first bearing provided between the intermediate moveable element and the button and arranged to move the button along the first axis when the intermediate moveable element moves, wherein the first bearing comprises at least one ramp and at least one ball bearing arranged to roll along the at least one ramp; and at least one shape memory alloy, SMA, actuator wire coupled to the at least one intermediate moveable element and arranged to, on contraction, laterally move the intermediate moveable element in the plane, thereby driving movement of the button along the first axis and providing a haptic effect. a housing comprising a cavity ; a button provided within the cavity and moveable along a first axis within the cavity, wherein the first axis is perpendicular to a contact surface of the button; at least one intermediate moveable element provided within the cavity in contact with the button and moveable in a plane defined by the first axis and a second axis, the second axis being perpendicular to the first axis, and arranged to drive movement of the button along the first axis, wherein the at least one intermediate moveable element is in indirect contact with the button, and the assembly comprises a first bearing provided between the intermediate moveable element and the button and arranged to move the button along the first axis when the intermediate moveable element moves, wherein the first bearing comprises at least one ramp and at least one ball bearing arranged to roll along the at least one ramp; and at least one shape memory alloy, SMA, actuator wire coupled to the at least one intermediate moveable element and arranged to, on contraction, laterally move the intermediate moveable element in the plane, thereby driving movement of the button along the first axis and providing a haptic effect.
A food, comprising: a. a food piece; and b. a coating on at least a portion of a surface of the food piece, the coating being solid at 110°F (43 °C), and consisting essentially of: i. 90% to 97% chocolate; and ii. 3% to 10% palm stearin having a melt point of at least 130° F (54 °C). a. a food piece; and b. a coating on at least a portion of a surface of the food piece, the coating being solid at 110°F (43 °C), and consisting essentially of: i. 90% to 97% chocolate; and ii. 3% to 10% palm stearin having a melt point of at least 130° F (54 °C). i. 90% to 97% chocolate; and ii. 3% to 10% palm stearin having a melt point of at least 130° F (54 °C).
A riser assembly comprising: a riser flow spool ; a riser isolation device and an upper riser disconnect assembly ; wherein at least the riser flow spool is located on a riser below a riser tension ring and wherein the upper riser disconnect assembly is located above the riser tension ring. a riser flow spool ; a riser isolation device and an upper riser disconnect assembly ; wherein at least the riser flow spool is located on a riser below a riser tension ring and wherein the upper riser disconnect assembly is located above the riser tension ring.
A soft magnetic alloy, comprising a composition expressed by a formula: Fe a B b Si c , wherein a is in the range of 84.5 to 91.0 at%, b is in the range of 5.3 to 9.0 at%, and c is in the range of 3.8 to 6.5 at%, wherein the content ratio of B to Si, i.e. b/c, is 1.4 so that the amount of saturated magnetic induction of the soft magnetic alloy is in the range of 1.78 to 1.95T, a resistivity of the soft magnetic alloy is in the range of 45.7 to 52.6 μΩ·cm, and a saturated Magnetization is in the range of 182.2x10 3 A/m to 199.2x10 3 A/m (182.2 to 199.2 emu/g) so as to be used at frequency band in the range of 110 to 250kHz wherein a is in the range of 84.5 to 91.0 at%, b is in the range of 5.3 to 9.0 at%, and c is in the range of 3.8 to 6.5 at%, wherein the content ratio of B to Si, i.e. b/c, is 1.4 so that the amount of saturated magnetic induction of the soft magnetic alloy is in the range of 1.78 to 1.95T, a resistivity of the soft magnetic alloy is in the range of 45.7 to 52.6 μΩ·cm, and a saturated Magnetization is in the range of 182.2x10 3 A/m to 199.2x10 3 A/m (182.2 to 199.2 emu/g) so as to be used at frequency band in the range of 110 to 250kHz
An austenitic stainless steel having a chemical composition comprising, in mass %: 0.005 to 0.07 % C; 0.1 to 1.2 % Si; 3.2 to 6.5 % Mn; 9 to 14 % Ni; a total of not less than 0.005 % and up to 2 % of at least one of Cu and Co; 19 to 24 % Cr; 1 to 4 % Mo; 0.05 to 0.38 % Nb; 0.15 to 0.45 %N; up to 0.05 % Al; up to 0.03 % P; up to 0.002 % S; up to 0.02 % O; 0 to 0.5 % V; 0 to 0.5 % Ti; 0 to 0.01 % B; 0 to 0.05 % Ca; 0 to 0.05 % Mg; 0 to 0.5 % REM; and the balance being Fe and impurities, where an amount of Nb analyzed as a residue after electrolytic extraction is 0.01 to 0.28 mass %, wherein the amount of Nb analyzed as a residue after electrolytic extraction is measured by: obtaining a test material from the austenitic stainless steel; subjecting the test material to anodic dissolution at a current density of 20 to 25 mA/cm 2 with constant-current electrolysis using, as the electrolyte, 10 volume % acetylacetone-1 mass % tetramethyl ammonium chloride methanol solution to extract the residue comprising carbonitrides and nitrides; subjecting the extracted residue to acid decomposition and performing high-frequency inductively coupled plasma emission analysis to measure the mass of Nb in the residue; and dividing the mass of Nb in the residue by an amount of dissolution of the test material. 0.005 to 0.07 % C; 0.1 to 1.2 % Si; 3.2 to 6.5 % Mn; 9 to 14 % Ni; a total of not less than 0.005 % and up to 2 % of at least one of Cu and Co; 19 to 24 % Cr; 1 to 4 % Mo; 0.05 to 0.38 % Nb; 0.15 to 0.45 %N; up to 0.05 % Al; up to 0.03 % P; up to 0.002 % S; up to 0.02 % O; 0 to 0.5 % V; 0 to 0.5 % Ti; 0 to 0.01 % B; 0 to 0.05 % Ca; 0 to 0.05 % Mg; 0 to 0.5 % REM; and the balance being Fe and impurities, obtaining a test material from the austenitic stainless steel; subjecting the test material to anodic dissolution at a current density of 20 to 25 mA/cm 2 with constant-current electrolysis using, as the electrolyte, 10 volume % acetylacetone-1 mass % tetramethyl ammonium chloride methanol solution to extract the residue comprising carbonitrides and nitrides; subjecting the extracted residue to acid decomposition and performing high-frequency inductively coupled plasma emission analysis to measure the mass of Nb in the residue; and dividing the mass of Nb in the residue by an amount of dissolution of the test material.
Heat exchanger , in particular a high-pressure heat exchanger for urea synthesis, comprising a plurality of heat-transfer tubes for transporting a first fluid (F1) in order to transfer heat between the first fluid (F1) and a second fluid (F2) via the heat-transfer tubes , characterized in that a fibre-optic sensor is respectively arranged on one or more of the heat-transfer tubes , wherein the fibre-optic sensor is designed to interferometrically determine an elastic oscillation, in particular an eigen oscillation, of the respective heat-transfer tube during an operation of the heat exchanger in order to determine a tube wall thickness of the respective heat-transfer tube during an operation of the heat exchanger .
Method for checking a semiconductor switch (S3) for a fault, in which the semiconductor switch (S3) is driven with a PWM signal with variable duty cycle, wherein, when the semiconductor switch (S3) is operated with a duty cycle of 100% or 0% the current measurement of the overall system is evaluated, while, when the semiconductor switch is operated with a duty cycle between 0% and 100% the voltage pulses generated across the semiconductor switch are evaluated, wherein the voltage pulses generated across the semiconductor switch (S3) are counted for the evaluation, and as a result of the evaluation a short circuit or an open circuit of the semiconductor (S3) switch is detected if the latter does not generate voltage pulses.